Current Drug Metabolism

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Back Subscribe
Review Article

Emerging Approaches in Data-Driven Drug Discovery for Rare Diseases

Author(s): Mohamed Abbas*, Muneer Parayangat, Mohammad Alaa Hussain Al-Hamami, Hashim Elshafie, Mohamad Yahya H. Al-Shamri and R Resmi

Volume 26, Issue 8, 2025

Published on: 25 August, 2025

Page: [561 - 577] Pages: 17

DOI: 10.2174/0113892002383220250729100138

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Rare diseases present unique challenges in drug discovery and development, primarily due to small patient populations, limited clinical data, and significant variability in disease mechanisms. The primary objective of this review is to examine the integration of pharmacokinetics (PK) and drug metabolism data into data-driven drug discovery approaches, particularly in the context of rare diseases. By incorporating advanced computational techniques such as Machine Learning (ML) and Artificial Intelligence (AI), researchers can better predict PK parameters, optimize drug candidates, and identify personalized therapeutic strategies. AI integration with genomic and proteomic data reveals previously unidentifiable pathways, fostering collaboration among researchers, clinicians, and pharmaceutical companies. This interdisciplinary approach reduces development timelines and costs while enhancing the precision and effectiveness of therapies for patients with rare diseases. This review highlights the critical role of absorption, distribution, metabolism, and excretion (ADME) in understanding drug behavior in genetically diverse populations, thereby enabling the development of tailored treatments for patients with rare diseases. Additionally, it evaluates the opportunities and limitations of integrating PK/PD (pharmacodynamics) models with multi-omics data to improve drug discovery efficiency. Key examples of enzyme-drug interactions, metabolic pathway analysis, and AIbased PK simulations are discussed to illustrate advancements in predictive accuracy and drug safety. This review concludes by emphasizing the transformative potential of integrating PK and metabolism studies into the broader framework of data-driven drug discovery, ultimately accelerating therapeutic innovation and addressing unmet medical needs in rare diseases.

Keywords: Rare diseases, computational drug discovery, machine learning, artificial intelligence, high-throughput screening, digital twin models, personalized medicine.

« Previous

Graphical Abstract

[1]
Hu, F.; Yang, H.; Qiu, L.; Wei, S.; Hu, H.; Zhou, H. Spatial structure and organization of the medical device industry urban network in China: Evidence from specialized, refined, distinctive, and innovative firms. Front. Public Health, 2025, 13, 1518327.
[http://dx.doi.org/10.3389/fpubh.2025.1518327] [PMID: 40161027]
[2]
Qiu, L.; Yu, R.; Hu, F.; Zhou, H.; Hu, H. How can China’s medical manufacturing listed firms improve their technological innovation efficiency? An analysis based on a three-stage DEA model and corporate governance configurations. Technol. Forecast. Soc. Change, 2023, 194, 122684.
[http://dx.doi.org/10.1016/j.techfore.2023.122684]
[3]
Xing, Y.; Yang, K.; Lu, A.; Mackie, K.; Guo, F. Sensors and devices guided by artificial intelligence for personalized pain medicine. Cyborg Bionic Syst., 2024, 5, 0160.
[http://dx.doi.org/10.34133/cbsystems.0160] [PMID: 39282019]
[4]
Abdallah, S.; Sharifa, M.; I Kh Almadhoun, M.K.; Khawar, M.M.; Shaikh, U.; Balabel, K.M.; Saleh, I.; Manzoor, A.; Mandal, A.K.; Ekomwereren, O.; Khine, W.M.; Oyelaja, O.T. The impact of artificial intelligence on optimizing diagnosis and treatment plans for rare genetic disorders. Cureus, 2023, 15(10), e46860.
[http://dx.doi.org/10.7759/cureus.46860] [PMID: 37954711]
[5]
Decherchi, S.; Pedrini, E.; Mordenti, M.; Cavalli, A.; Sangiorgi, L. Opportunities and challenges for machine learning in rare diseases. Front. Med., 2021, 8, 747612.
[http://dx.doi.org/10.3389/fmed.2021.747612] [PMID: 34676229]
[6]
Hasani, N.; Farhadi, F.; Morris, M.A.; Nikpanah, M.; Rahmim, A.; Xu, Y.; Pariser, A.; Collins, M.T.; Summers, R.M.; Jones, E.; Siegel, E.; Saboury, B. Artificial intelligence in medical imaging and its impact on the rare disease community: Threats, challenges and opportunities. PET Clin., 2022, 17(1), 13-29.
[http://dx.doi.org/10.1016/j.cpet.2021.09.009] [PMID: 34809862]
[7]
Hirsch, M.C.; Ronicke, S.; Krusche, M.; Wagner, A.D. Rare diseases 2030: How augmented AI will support diagnosis and treatment of rare diseases in the future. Ann. Rheum. Dis., 2020, 79(6), 740-743.
[http://dx.doi.org/10.1136/annrheumdis-2020-217125] [PMID: 32209541]
[8]
Faviez, C.; Chen, X.; Garcelon, N.; Neuraz, A.; Knebelmann, B.; Salomon, R.; Lyonnet, S.; Saunier, S.; Burgun, A. Diagnosis support systems for rare diseases: A scoping review. Orphanet J. Rare Dis., 2020, 15(1), 94.
[http://dx.doi.org/10.1186/s13023-020-01374-z] [PMID: 32299466]
[9]
Lee, J.; Liu, C.; Kim, J.; Chen, Z.; Sun, Y.; Rogers, J.R.; Chung, W.K.; Weng, C. Deep learning for rare disease: A scoping review. J. Biomed. Inform., 2022, 135, 104227.
[http://dx.doi.org/10.1016/j.jbi.2022.104227] [PMID: 36257483]
[10]
Siddiq, M. Revolutionizing drug discovery; Transformative role of machine learning. BULLET: Jurnal Multidisiplin Ilmu, 2022, 1(02), 162-170.
[11]
Paul, D.; Sanap, G.; Shenoy, S.; Kalyane, D.; Kalia, K.; Tekade, R.K. Artificial intelligence in drug discovery and development. Drug Discov. Today, 2021, 26(1), 80-93.
[http://dx.doi.org/10.1016/j.drudis.2020.10.010] [PMID: 33099022]
[12]
Boniolo, F.; Dorigatti, E.; Ohnmacht, A.J.; Saur, D.; Schubert, B.; Menden, M.P. Artificial intelligence in early drug discovery enabling precision medicine. Expert Opin. Drug Discov., 2021, 16(9), 991-1007.
[http://dx.doi.org/10.1080/17460441.2021.1918096] [PMID: 34075855]
[13]
Davenport, T.; Kalakota, R. The potential for artificial intelligence in healthcare. Future Healthc. J., 2019, 6(2), 94-98.
[http://dx.doi.org/10.7861/futurehosp.6-2-94] [PMID: 31363513]
[14]
Jumper, J.; Evans, R.; Pritzel, A.; Green, T.; Figurnov, M.; Ronneberger, O.; Tunyasuvunakool, K.; Bates, R.; Žídek, A.; Potapenko, A.; Bridgland, A.; Meyer, C.; Kohl, S.A.A.; Ballard, A.J.; Cowie, A.; Romera-Paredes, B.; Nikolov, S.; Jain, R.; Adler, J.; Back, T.; Petersen, S.; Reiman, D.; Clancy, E.; Zielinski, M.; Steinegger, M.; Pacholska, M.; Berghammer, T.; Bodenstein, S.; Silver, D.; Vinyals, O.; Senior, A.W.; Kavukcuoglu, K.; Kohli, P.; Hassabis, D. Highly accurate protein structure prediction with AlphaFold. Nature, 2021, 596(7873), 583-589.
[http://dx.doi.org/10.1038/s41586-021-03819-2] [PMID: 34265844]
[15]
Liu, G.; Catacutan, D.B.; Rathod, K.; Swanson, K.; Jin, W.; Mohammed, J.C.; Chiappino-Pepe, A.; Syed, S.A.; Fragis, M.; Rachwalski, K.; Magolan, J.; Surette, M.G.; Coombes, B.K.; Jaakkola, T.; Barzilay, R.; Collins, J.J.; Stokes, J.M. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol., 2023, 19(11), 1342-1350.
[http://dx.doi.org/10.1038/s41589-023-01349-8] [PMID: 37231267]
[16]
Wong, F.; Zheng, E.J.; Valeri, J.A.; Donghia, N.M.; Anahtar, M.N.; Omori, S.; Li, A.; Cubillos-Ruiz, A.; Krishnan, A.; Jin, W.; Manson, A.L.; Friedrichs, J.; Helbig, R.; Hajian, B.; Fiejtek, D.K.; Wagner, F.F.; Soutter, H.H.; Earl, A.M.; Stokes, J.M.; Renner, L.D.; Collins, J.J. Discovery of a structural class of antibiotics with explainable deep learning. Nature, 2024, 626(7997), 177-185.
[http://dx.doi.org/10.1038/s41586-023-06887-8] [PMID: 38123686]
[17]
Hasselgren, C.; Oprea, T.I. Artificial intelligence for drug discovery: Are we there yet? Annu. Rev. Pharmacol. Toxicol., 2024, 64, 527-550.
[http://dx.doi.org/10.1146/annurev-pharmtox-040323-040828] [PMID: 37738505]
[18]
Alizadehsani, R.; Oyelere, S.S.; Hussain, S.; Calixto, R.R.; de Albuquerque, V.H.C. Explainable artificial intelligence for drug discovery and development—A comprehensive survey. arXiv, 2023, arXiv:2309.12177v2.
[http://dx.doi.org/10.48550/arXiv.2309.12177]
[19]
Doron, G.; Genway, S.; Roberts, M.; Jasti, S. New Horizons: Pioneering Pharmaceutical R&D with Generative AI from lab to the clinic—An industry perspective. arXiv, 2023, arXiv:2312.12482v1.
[http://dx.doi.org/10.48550/arXiv.2312.12482]
[20]
Gupta, A. CardiGraphormer: Unveiling the power of self-supervised learning in revolutionizing drug discovery. arXiv, 2023, arXiv:2307.00859v4.
[http://dx.doi.org/10.48550/arXiv.2307.00859]
[21]
Tambuyzer, E.; Vandendriessche, B.; Austin, C.P.; Brooks, P.J.; Larsson, K.; Miller Needleman, K.I.; Valentine, J.; Davies, K.; Groft, S.C.; Preti, R.; Oprea, T.I.; Prunotto, M. Therapies for rare diseases: Therapeutic modalities, progress and challenges ahead. Nat. Rev. Drug Discov., 2020, 19(2), 93-111.
[http://dx.doi.org/10.1038/s41573-019-0049-9] [PMID: 31836861]
[22]
Liu, J.; Barrett, J.S.; Leonardi, E.T.; Lee, L.; Roychoudhury, S.; Chen, Y.; Trifillis, P. Natural history and real-world data in rare diseases: Applications, limitations, and future perspectives. J. Clin. Pharmacol., 2022, 62(S2), S38-S55. (Suppl. 2)
[http://dx.doi.org/10.1002/jcph.2134] [PMID: 36461748]
[23]
Peng, J.; Jury, E.C.; Dönnes, P.; Ciurtin, C. Machine learning techniques for personalised medicine approaches in immune-mediated chronic inflammatory diseases: Applications and challenges. Front. Pharmacol., 2021, 12, 720694.
[http://dx.doi.org/10.3389/fphar.2021.720694] [PMID: 34658859]
[24]
Quazi, S. RETRACTED ARTICLE: Artificial intelligence and machine learning in precision and genomic medicine. Med. Oncol., 2022, 39(8), 120.
[http://dx.doi.org/10.1007/s12032-022-01711-1] [PMID: 35704152]
[25]
Schaefer, J.; Lehne, M.; Schepers, J.; Prasser, F.; Thun, S. The use of machine learning in rare diseases: A scoping review. Orphanet J. Rare Dis., 2020, 15(1), 145.
[http://dx.doi.org/10.1186/s13023-020-01424-6]
[26]
Kumar Tripathi, M.; Nath, A.; Singh, P. Evolving scenario of big data and artificial intelligence (AI) in drug discovery. Mol. Divers., 2021, 25(3), 1439-1460.
[http://dx.doi.org/10.1007/s11030-021-10256-w] [PMID: 34159484]
[27]
Wojtara, M.; Rana, E.; Rahman, T.; Khanna, P.; Singh, H. Artificial intelligence in rare disease diagnosis and treatment. Clin. Transl. Sci., 2023, 16(11), 2106-2111.
[http://dx.doi.org/10.1111/cts.13619]
[28]
Stankevičiūtė, K.; Woillard, J-B.; Peck, R.W.; Marquet, P.; van der Schaar, M. Bridging the worlds of pharmacometrics and machine learning. Clin. Pharmacokinet., 2023, 62(11), 1551-1565.
[http://dx.doi.org/10.1007/s40262-023-01310-x] [PMID: 37803104]
[29]
Brasil, S.; Neves, C.J.; Rijoff, T.; Falcão, M.; Valadão, G.; Videira, P.A.; dos Reis Ferreira, V. Artificial intelligence in epigenetic studies: Shedding light on rare diseases. Front. Mol. Biosci., 2021, 8, 648012.
[http://dx.doi.org/10.3389/fmolb.2021.648012] [PMID: 34026829]
[30]
Tiwari, P.C.; Pal, R.; Chaudhary, M.J.; Nath, R. Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges. Drug Dev. Res., 2023, 84(8), 1652-1663.
[http://dx.doi.org/10.1002/ddr.22115] [PMID: 37712494]
[31]
Hallowell, N.; Badger, S.; McKay, F.; Kerasidou, A.; Nellåker, C. Democratising or disrupting diagnosis? Ethical issues raised by the use of AI tools for rare disease diagnosis. SSM Qual. Res. Health, 2023, 3, 100240.
[http://dx.doi.org/10.1016/j.ssmqr.2023.100240] [PMID: 37426704]
[32]
Denton, N.; Mulberg, A.E.; Molloy, M.; Charleston, S.; Fajgenbaum, D.C.; Marsh, E.D.; Howard, P. Sharing is caring: A call for a new era of rare disease research and development. Orphanet J. Rare Dis., 2022, 17(1), 389.
[http://dx.doi.org/10.1186/s13023-022-02529-w] [PMID: 36303170]
[33]
Sahu, M.; Gupta, R.; Ambasta, R.K.; Kumar, P. Artificial intelligence and machine learning in precision medicine: A paradigm shift in big data analysis. Prog. Mol. Biol. Transl. Sci., 2022, 190(1), 57-100.
[http://dx.doi.org/10.1016/bs.pmbts.2022.03.002] [PMID: 36008002]
[34]
Gangwal, A.; Ansari, A.; Ahmad, I.; Azad, A.K.; Wan Sulaiman, W.M.A. Current strategies to address data scarcity in artificial intelligence-based drug discovery: A comprehensive review. Comput. Biol. Med., 2024, 179, 108734.
[http://dx.doi.org/10.1016/j.compbiomed.2024.108734] [PMID: 38964243]
[35]
Siramshetty, V.B.; Xu, X.; Shah, P. Artificial intelligence in ADME property prediction. Methods Mol. Biol., 2024, 2714, 307-327.
[http://dx.doi.org/10.1007/978-1-0716-3441-7_17] [PMID: 37676606]
[36]
Du, B-X.; Long, Y.; Li, X.; Wu, M.; Shi, J-Y. CMMS-GCL: Crossmodality metabolic stability prediction with graph contrastive learning. Bioinformatics, 2023, 39(8), btad503. Aug;
[http://dx.doi.org/10.1093/bioinformatics/btad503]
[37]
Pillai, N.; Abos, A.; Teutonico, D.; Mavroudis, P.D. Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure. Clin. Transl. Sci., 2024, 17(5), e13824.
[http://dx.doi.org/10.1111/cts.13824] [PMID: 38752574]
[38]
Subramanian, M.; Wojtusciszyn, A.; Favre, L.; Boughorbel, S.; Shan, J.; Letaief, K.B.; Pitteloud, N.; Chouchane, L. Precision medicine in the era of artificial intelligence: Implications in chronic disease management. J. Transl. Med., 2020, 18(1), 472.
[http://dx.doi.org/10.1186/s12967-020-02658-5] [PMID: 33298113]
[39]
Nadella, G.S.; Satish, S.; Meduri, K.; Meduri, S.S. A systematic literature review of advancements, challenges and future directions of AI and ML in healthcare. Int. J. Mach Learn. Sustain. Dev., 2023, 5(3), 115-130.
[40]
Roessler, H.I.; Knoers, N.V.A.M.; van Haelst, M.M.; van Haaften, G. Drug repurposing for rare diseases. Trends Pharmacol. Sci., 2021, 42(4), 255-267.
[http://dx.doi.org/10.1016/j.tips.2021.01.003] [PMID: 33563480]
[41]
Vatansever, S.; Schlessinger, A.; Wacker, D.; Kaniskan, H.Ü.; Jin, J.; Zhou, M.M.; Zhang, B. Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions. Med. Res. Rev., 2021, 41(3), 1427-1473.
[http://dx.doi.org/10.1002/med.21764] [PMID: 33295676]
[42]
Li, Y.; Wang, Z.; Li, Y.; Du, J.; Gao, X.; Li, Y.; Lai, L. A combination of machine learning and pbpk modeling approach for pharmacokinetics prediction of small molecules in humans. Pharm. Res., 2024, 41(7), 1369-1379.
[http://dx.doi.org/10.1007/s11095-024-03725-y]
[43]
Feng, X.; Ma, Z.; Yu, C.; Xin, R. MRNDR: Multihead attention-based recommendation network for drug repurposing. J. Chem. Inf. Model., 2024, 64(7), 2654-2669.
[http://dx.doi.org/10.1021/acs.jcim.3c01726] [PMID: 38373300]
[44]
Zhou, Y.; Li, Q.; Pan, R.; Wang, Q.; Zhu, X.; Yuan, C.; Cai, F.; Gao, Y.; Cui, Y. Regulatory roles of three miRNAs on allergen mRNA expression in Tyrophagus putrescentiae. Allergy, 2022, 77(2), 469-482.
[http://dx.doi.org/10.1111/all.15111] [PMID: 34570913]
[45]
Zhou, Y.; Li, L.; Yu, Z.; Gu, X.; Pan, R.; Li, Q.; Yuan, C.; Cai, F.; Zhu, Y.; Cui, Y. Dermatophagoides pteronyssinusallergen Der p 22: Cloning, expression, IgE ‐binding in asthmatic children, and immunogenicity. Pediatr. Allergy Immunol., 2022, 33(8), e13835.
[http://dx.doi.org/10.1111/pai.13835] [PMID: 36003049]
[46]
Li, J.P.O.; Liu, H.; Ting, D.S.J.; Jeon, S.; Chan, R.V.P.; Kim, J.E.; Sim, D.A.; Thomas, P.B.M.; Lin, H.; Chen, Y.; Sakomoto, T.; Loewenstein, A.; Lam, D.S.C.; Pasquale, L.R.; Wong, T.Y.; Lam, L.A.; Ting, D.S.W. Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective. Prog. Retin. Eye Res., 2021, 82, 100900.
[http://dx.doi.org/10.1016/j.preteyeres.2020.100900] [PMID: 32898686]
[47]
de la Lastra, J.M.P.; Wardell, S.J.T.; Pal, T.; de la Fuente-Nunez, C.; Pletzer, D. From data to decisions: Leveraging artificial intelligence and machine learning in combating antimicrobial resistance – A comprehensive review. J. Med. Syst., 2024, 48(1), 71.
[http://dx.doi.org/10.1007/s10916-024-02089-5] [PMID: 39088151]
[48]
Javaid, M.; Haleem, A.; Pratap Singh, R.; Suman, R.; Rab, S. Significance of machine learning in healthcare: Features, pillars and applications. Int. J. Intell. Netw, 2022, 3, 58-73.
[http://dx.doi.org/10.1016/j.ijin.2022.05.002]
[49]
Fan, Z.; Yan, Z.; Wen, S. Deep learning and artificial intelligence in sustainability: A review of SDGs, renewable energy, and environmental health. Sustainability, 2023, 15(18), 13493.
[http://dx.doi.org/10.3390/su151813493]
[50]
Tucker, A.; Wang, Z.; Rotalinti, Y.; Myles, P. Generating high-fidelity synthetic patient data for assessing machine learning healthcare software. NPJ Digit. Med., 2020, 3(1), 147.
[http://dx.doi.org/10.1038/s41746-020-00353-9] [PMID: 33299100]
[51]
Relling, M.V.; Klein, T.E.; Gammal, R.S.; Whirl-Carrillo, M.; Hoffman, J.M.; Caudle, K.E. The clinical pharmacogenetics implementation consortium: 10 years later. Clin. Pharmacol. Ther., 2020, 107(1), 171-175.
[http://dx.doi.org/10.1002/cpt.1651] [PMID: 31562822]
[52]
Chenoweth, M.J.; Giacomini, K.M.; Pirmohamed, M.; Hill, S.L.; van Schaik, R.H.N.; Schwab, M.; Shuldiner, A.R.; Relling, M.V.; Tyndale, R.F. Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities. Clin. Pharmacol. Ther., 2020, 107(1), 57-61.
[http://dx.doi.org/10.1002/cpt.1664] [PMID: 31696505]
[53]
Zhao, Chen; Kang, Jun; Li, Yuwen; Wang, Yan; Tang, Xiaoying; Jiang, Zhenqi Carbon-based stimuli-responsive nanomaterials: Classification and application. Cyborg Bionic Syst., 2023, 4, 0022.
[http://dx.doi.org/10.34133/cbsystems.0022]
[54]
Ma, Z.; Chen, Z.; Zheng, X.; Wang, T.; You, Y.; Zou, S.; Wang, Y. A biological immunity-based neuro prototype for few-shot anomaly detection with character embedding. Cyborg Bionic Syst., 2024, 5, 0086.
[http://dx.doi.org/10.34133/cbsystems.0086] [PMID: 38234315]
[55]
Wang, Y.; Li, H.; Fan, R.; Lv, H.; Hua, S.; Xie, H.; Tang, T.; Luo, J.; Xia, Z. The effects of ferulic acid on the pharmacokinetics of warfarin in rats after biliary drainage. Drug Des. Devel. Ther., 2016, 10, 2173-2180.
[http://dx.doi.org/10.2147/DDDT.S107917] [PMID: 27462142]
[56]
Setty, S.T.; Scott-Boyer, M.P.; Cuppens, T.; Droit, A. New developments and possibilities in reanalysis and reinterpretation of whole exome sequencing datasets for unsolved rare diseases using machine learning approaches. Int. J. Mol. Sci., 2022, 23(12), 6792.
[http://dx.doi.org/10.3390/ijms23126792] [PMID: 35743235]
[57]
Zhao, X.; Liu, T.; He, Y.N.; Fang, W.; Li, X.; Jiang, W. Comparison of the efficacy and safety of low-dose antihypertensive combinations in patients with hypertension: Protocol for a systematic review and network meta-analysis. BMJ Open, 2024, 14(10), e086323.
[http://dx.doi.org/10.1136/bmjopen-2024-086323] [PMID: 39448211]
[58]
Feng, C.; Wang, Y.; Xu, J.; Zheng, Y.; Zhou, W.; Wang, Y.; Luo, C. Precisely tailoring molecular structure of doxorubicin prodrugs to enable stable nanoassembly, rapid activation, and potent antitumor effect. Pharmaceutics, 2024, 16(12), 1582.
[http://dx.doi.org/10.3390/pharmaceutics16121582] [PMID: 39771561]
[59]
Visibelli, A.; Roncaglia, B.; Spiga, O.; Santucci, A. The impact of artificial intelligence in the odyssey of rare diseases. Biomedicines, 2023, 11(3), 887.
[http://dx.doi.org/10.3390/biomedicines11030887] [PMID: 36979866]
[60]
Souza, Í.P.; Androlage, J.S.; Bellato, R. A qualitative approach to rare genetic diseases: An integrative review of the national and international literature. Cien. Saude Colet., 2022, 24(10), 3683-3700.
[http://dx.doi.org/10.1590/1413-812320182410.17822019] [PMID: 31576998]
[61]
Jeziorski, K.; Olszewski, R. Artificial intelligence in oncology. Appl. Sci., 2025, 15(1), 269.
[http://dx.doi.org/10.3390/app15010269]
[62]
Donadio, D.; Terry, S.F. The application of artificial intelligence in the diagnosis of cancer and rare genetic diseases. Genet. Test. Mol. Biomarkers, 2023, 27(7), 203-204.
[http://dx.doi.org/10.1089/gtmb.2023.29074.persp] [PMID: 37471205]
[63]
Xu, J.; Yang, P.; Xue, S.; Sharma, B.; Sanchez-Martin, M.; Wang, F.; Beaty, K.A.; Dehan, E.; Parikh, B. Translating cancer genomics into precision medicine with artificial intelligence: Applications, challenges and future perspectives. Hum. Genet., 2019, 138(2), 109-124.
[http://dx.doi.org/10.1007/s00439-019-01970-5] [PMID: 30671672]
[64]
Ivanisevic, T.; Sewduth, R.N. Multi-omics integration for the design of novel therapies and the identification of novel biomarkers. Proteomes, 2023, 11(4), 34.
[http://dx.doi.org/10.3390/proteomes11040034] [PMID: 37873876]
[65]
Tabor, H.K.; Goldenberg, A. What precision medicine can learn from rare genetic disease research and translation. AMA J. Ethics, 2018, 20(9), E834-E840.
[http://dx.doi.org/10.1001/amajethics.2018.834] [PMID: 30242814]
[66]
Foksinska, A.; Crowder, C.M.; Crouse, A.B.; Henrikson, J.; Byrd, W.E.; Rosenblatt, G.; Patton, M.J.; He, K.; Tran-Nguyen, T.K.; Zheng, M.; Ramsey, S.A.; Amin, N.; Osborne, J.; Might, M. The precision medicine process for treating rare disease using the artificial intelligence tool mediKanren. Front. Artif. Intell., 2022, 5, 910216.
[http://dx.doi.org/10.3389/frai.2022.910216] [PMID: 36248623]
[67]
Sebastian, A.M.; Peter, D. Artificial intelligence in cancer research: Trends, challenges and future directions. Life, 2022, 12(12), 1991.
[http://dx.doi.org/10.3390/life12121991] [PMID: 36556356]
[68]
Topol, E.J. High-performance medicine: The convergence of human and artificial intelligence. Nat. Med., 2019, 25(1), 44-56.
[http://dx.doi.org/10.1038/s41591-018-0300-7] [PMID: 30617339]
[69]
Esteva, A.; Kuprel, B.; Novoa, R.A.; Ko, J.; Swetter, S.M.; Blau, H.M.; Thrun, S. Dermatologist-level classification of skin cancer with deep neural networks. Nature, 2017, 542(7639), 115-118.
[http://dx.doi.org/10.1038/nature21056] [PMID: 28117445]
[70]
Gulshan, V.; Peng, L.; Coram, M.; Stumpe, M.C.; Wu, D.; Narayanaswamy, A.; Venugopalan, S.; Widner, K.; Madams, T.; Cuadros, J.; Kim, R.; Raman, R.; Nelson, P.C.; Mega, J.L.; Webster, D.R. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA, 2016, 316(22), 2402-2410.
[http://dx.doi.org/10.1001/jama.2016.17216] [PMID: 27898976]
[71]
Litjens, G.; Kooi, T.; Bejnordi, B.E.; Setio, A.A.A.; Ciompi, F.; Ghafoorian, M.; van der Laak, J.A.W.M.; van Ginneken, B.; Sánchez, C.I. A survey on deep learning in medical image analysis. Med. Image Anal., 2017, 42, 60-88.
[http://dx.doi.org/10.1016/j.media.2017.07.005] [PMID: 28778026]
[72]
LeCun, Y.; Bengio, Y.; Hinton, G. Deep learning. Nature, 2015, 521(7553), 436-444.
[http://dx.doi.org/10.1038/nature14539] [PMID: 26017442]
[73]
Obermeyer, Z.; Emanuel, E.J. Predicting the future—big data, machine learning, and clinical medicine. N. Engl. J. Med., 2016, 375(13), 1216-1219.
[http://dx.doi.org/10.1056/NEJMp1606181] [PMID: 27682033]
[74]
Wright, C.F.; FitzPatrick, D.R.; Firth, H.V. Paediatric genomics: Diagnosing rare disease in children. Nat. Rev. Genet., 2018, 19(5), 253-268.
[http://dx.doi.org/10.1038/nrg.2017.116] [PMID: 29398702]
[75]
Yang, Y.; Muzny, D.M.; Reid, J.G.; Bainbridge, M.N.; Willis, A.; Ward, P.A.; Braxton, A.; Beuten, J.; Xia, F.; Niu, Z.; Hardison, M.; Person, R.; Bekheirnia, M.R.; Leduc, M.S.; Kirby, A.; Pham, P.; Scull, J.; Wang, M.; Ding, Y.; Plon, S.E.; Lupski, J.R.; Beaudet, A.L.; Gibbs, R.A.; Eng, C.M. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med., 2013, 369(16), 1502-1511.
[http://dx.doi.org/10.1056/NEJMoa1306555] [PMID: 24088041]
[76]
Lionel, A.C.; Costain, G.; Monfared, N.; Walker, S.; Reuter, M.S.; Hosseini, S.M.; Thiruvahindrapuram, B.; Merico, D.; Jobling, R.; Nalpathamkalam, T.; Pellecchia, G.; Sung, W.W.L.; Wang, Z.; Bikangaga, P.; Boelman, C.; Carter, M.T.; Cordeiro, D.; Cytrynbaum, C.; Dell, S.D.; Dhir, P.; Dowling, J.J.; Heon, E.; Hewson, S.; Hiraki, L.; Inbar-Feigenberg, M.; Klatt, R.; Kronick, J.; Laxer, R.M.; Licht, C.; MacDonald, H.; Mercimek-Andrews, S.; Mendoza-Londono, R.; Piscione, T.; Schneider, R.; Schulze, A.; Silverman, E.; Siriwardena, K.; Snead, O.C.; Sondheimer, N.; Sutherland, J.; Vincent, A.; Wasserman, J.D.; Weksberg, R.; Shuman, C.; Carew, C.; Szego, M.J.; Hayeems, R.Z.; Basran, R.; Stavropoulos, D.J.; Ray, P.N.; Bowdin, S.; Meyn, M.S.; Cohn, R.D.; Scherer, S.W.; Marshall, C.R. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet. Med., 2018, 20(4), 435-443.
[http://dx.doi.org/10.1038/gim.2017.119] [PMID: 28771251]
[77]
Wenger, A.M.; Guturu, H.; Bernstein, J.A.; Bejerano, G. Systematic reanalysis of clinical exome data yields additional diagnoses: Implications for providers. Genet. Med., 2017, 19(2), 209-214.
[http://dx.doi.org/10.1038/gim.2016.88] [PMID: 27441994]
[78]
Trujillano, D.; Bertoli-Avella, A.M.; Kumar Kandaswamy, K.; Weiss, M.E.R.; Köster, J.; Marais, A.; Paknia, O.; Schröder, R.; Garcia-Aznar, J.M.; Werber, M.; Brandau, O.; Calvo del Castillo, M.; Baldi, C.; Wessel, K.; Kishore, S.; Nahavandi, N.; Eyaid, W.; Al Rifai, M.T.; Al-Rumayyan, A.; Al-Twaijri, W.; Alothaim, A.; Alhashem, A.; Al-Sannaa, N.; Al-Balwi, M.; Alfadhel, M.; Rolfs, A.; Abou Jamra, R. Clinical exome sequencing: Results from 2819 samples reflecting 1000 families. Eur. J. Hum. Genet., 2017, 25(2), 176-182.
[http://dx.doi.org/10.1038/ejhg.2016.146] [PMID: 27848944]
[79]
Retterer, K.; Juusola, J.; Cho, M.T.; Vitazka, P.; Millan, F.; Gibellini, F.; Vertino-Bell, A.; Smaoui, N.; Neidich, J.; Monaghan, K.G.; McKnight, D.; Bai, R.; Suchy, S.; Friedman, B.; Tahiliani, J.; Pineda-Alvarez, D.; Richard, G.; Brandt, T.; Haverfield, E.; Chung, W.K.; Bale, S. Clinical application of whole-exome sequencing across clinical indications. Genet. Med., 2016, 18(7), 696-704.
[http://dx.doi.org/10.1038/gim.2015.148] [PMID: 26633542]
[80]
Stark, Z.; Tan, T.Y.; Chong, B.; Brett, G.R.; Yap, P.; Walsh, M.; Yeung, A.; Peters, H.; Mordaunt, D.; Cowie, S.; Amor, D.J.; Savarirayan, R.; McGillivray, G.; Downie, L.; Ekert, P.G.; Theda, C.; James, P.A.; Yaplito-Lee, J.; Ryan, M.M.; Leventer, R.J.; Creed, E.; Macciocca, I.; Bell, K.M.; Oshlack, A.; Sadedin, S.; Georgeson, P.; Anderson, C.; Thorne, N.; Gaff, C.; White, S.M. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet. Med., 2016, 18(11), 1090-1096.
[http://dx.doi.org/10.1038/gim.2016.1] [PMID: 26938784]
[81]
Smedley, D.; Smith, K.R.; Martin, A.; Thomas, E.A.; McDonagh, E.M.; Cipriani, V.; Ellingford, J.M.; Arno, G.; Tucci, A.; Vandrovcova, J.; Chan, G.; Williams, H.J.; Ratnaike, T.; Wei, W.; Stirrups, K.; Ibanez, K.; Moutsianas, L.; Wielscher, M.; Need, A.; Barnes, M.R.; Vestito, L.; Buchanan, J.; Wordsworth, S.; Ashford, S.; Rehmström, K.; Li, E.; Fuller, G.; Twiss, P.; Spasic-Boskovic, O.; Halsall, S.; Floto, R.A.; Poole, K.; Wagner, A.; Mehta, S.G.; Gurnell, M.; Burrows, N.; James, R.; Penkett, C.; Dewhurst, E.; Gräf, S.; Mapeta, R.; Kasanicki, M.; Haworth, A.; Savage, H.; Babcock, M.; Reese, M.G.; Bale, M.; Baple, E.; Boustred, C.; Brittain, H.; de Burca, A.; Bleda, M.; Devereau, A.; Halai, D.; Haraldsdottir, E.; Hyder, Z.; Kasperaviciute, D.; Patch, C.; Polychronopoulos, D.; Matchan, A.; Sultana, R.; Ryten, M.; Tavares, A.L.T.; Tregidgo, C.; Turnbull, C.; Welland, M.; Wood, S.; Snow, C.; Williams, E.; Leigh, S.; Foulger, R.E.; Daugherty, L.C.; Niblock, O.; Leong, I.U.S.; Wright, C.F.; Davies, J.; Crichton, C.; Welch, J.; Woods, K.; Abulhoul, L.; Aurora, P.; Bockenhauer, D.; Broomfield, A.; Cleary, M.A.; Lam, T.; Dattani, M.; Footitt, E.; Ganesan, V.; Grunewald, S.; Compeyrot-Lacassagne, S.; Muntoni, F.; Pilkington, C.; Quinlivan, R.; Thapar, N.; Wallis, C.; Wedderburn, L.R.; Worth, A.; Bueser, T.; Compton, C.; Deshpande, C.; Fassihi, H.; Haque, E.; Izatt, L.; Josifova, D.; Mohammed, S.; Robert, L.; Rose, S.; Ruddy, D.; Sarkany, R.; Say, G.; Shaw, A.C.; Wolejko, A.; Habib, B.; Burns, G.; Hunter, S.; Grocock, R.J.; Humphray, S.J.; Robinson, P.N.; Haendel, M.; Simpson, M.A.; Banka, S.; Clayton-Smith, J.; Douzgou, S.; Hall, G.; Thomas, H.B.; O’Keefe, R.T.; Michaelides, M.; Moore, A.T.; Malka, S.; Pontikos, N.; Browning, A.C.; Straub, V.; Gorman, G.S.; Horvath, R.; Quinton, R.; Schaefer, A.M.; Yu-Wai-Man, P.; Turnbull, D.M.; McFarland, R.; Taylor, R.W.; O’Connor, E.; Yip, J.; Newland, K.; Morris, H.R.; Polke, J.; Wood, N.W.; Campbell, C.; Camps, C.; Gibson, K.; Koelling, N.; Lester, T.; Németh, A.H.; Palles, C.; Patel, S.; Roy, N.B.A.; Sen, A.; Taylor, J.; Cacheiro, P.; Jacobsen, J.O.; Seaby, E.G.; Davison, V.; Chitty, L.; Douglas, A.; Naresh, K.; McMullan, D.; Ellard, S.; Temple, I.K.; Mumford, A.D.; Wilson, G.; Beales, P.; Bitner-Glindzicz, M.; Black, G.; Bradley, J.R.; Brennan, P.; Burn, J.; Chinnery, P.F.; Elliott, P.; Flinter, F.; Houlden, H.; Irving, M.; Newman, W.; Rahman, S.; Sayer, J.A.; Taylor, J.C.; Webster, A.R.; Wilkie, A.O.M.; Ouwehand, W.H.; Raymond, F.L.; Chisholm, J.; Hill, S.; Bentley, D.; Scott, R.H.; Fowler, T.; Rendon, A.; Caulfield, M. 100,000 genomes pilot on rare-disease diagnosis in health care — Preliminary report. N. Engl. J. Med., 2021, 385(20), 1868-1880.
[http://dx.doi.org/10.1056/NEJMoa2035790] [PMID: 34758253]
[82]
Jacob, H.J.; Abrams, K.; Bick, D.P.; Brodie, K.; Dimmock, D.P.; Farrell, M. Genomics in clinical practice: Lessons from the front lines. Sci. Transl. Med., 2018, 10(463), eaao0177.
[http://dx.doi.org/10.1126/scitranslmed.3006468] [PMID: 23863829]
[83]
Gonzalez-Garay, M.L.; McGuire, A.L.; Pereira, S.; Caskey, C.T. Personalized genomic disease risk of volunteers. Proc. Natl. Acad. Sci. USA, 2013, 110(42), 16957-16962.
[http://dx.doi.org/10.1073/pnas.1315934110] [PMID: 24082139]
[84]
Wright, C.F.; McRae, J.F.; Clayton, S.; Gallone, G.; Aitken, S.; FitzGerald, T.W.; Jones, P.; Prigmore, E.; Rajan, D.; Lord, J.; Sifrim, A.; Kelsell, R.; Parker, M.J.; Barrett, J.C.; Hurles, M.E.; FitzPatrick, D.R.; Firth, H.V. Making new genetic diagnoses with old data: Iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders. Genet. Med., 2018, 20(10), 1216-1223.
[http://dx.doi.org/10.1038/gim.2017.246] [PMID: 29323667]
[85]
Jamei, M.; Marciniak, S.; Edwards, D.; Wragg, K.; Feng, K.; Barnett, A.; Rostami-Hodjegan, A. The Simcyp population based simulator: Architecture, implementation, and quality assurance. In Silico Pharmacol., 2013, 1, 9. Jun 3;
[http://dx.doi.org/10.1186/2193-9616-1-9] [PMID: 25505654]
[86]
Tyzack, J.D.; Kirchmair, J. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery. Chem. Biol. Drug Des., 2019, 93(4), 377-386.
[http://dx.doi.org/10.1111/cbdd.13445] [PMID: 30471192]
[87]
Sjögren, E.; Thörn, H.; Tannergren, C. In silico modeling of gastrointestinal drug absorption: Predictive performance of three physiologically based absorption models. Mol. Pharm., 2016, 13(6), 1763-1778.
[http://dx.doi.org/10.1021/acs.molpharmaceut.5b00861] [PMID: 26926043]
[88]
Lelieveld, S.H.; Reijnders, M.R.F.; Pfundt, R.; Yntema, H.G.; Kamsteeg, E.J.; de Vries, P.; de Vries, B.B.A.; Willemsen, M.H.; Kleefstra, T.; Löhner, K.; Vreeburg, M.; Stevens, S.J.C.; van der Burgt, I.; Bongers, E.M.H.F.; Stegmann, A.P.A.; Rump, P.; Rinne, T.; Nelen, M.R.; Veltman, J.A.; Vissers, L.E.L.M.; Brunner, H.G.; Gilissen, C. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat. Neurosci., 2016, 19(9), 1194-1196.
[http://dx.doi.org/10.1038/nn.4352] [PMID: 27479843]
[89]
Rajpurkar, P.; Irvin, J.; Ball, R.L.; Zhu, K.; Yang, B.; Mehta, H.; Duan, T.; Ding, D.; Bagul, A.; Langlotz, C.P.; Patel, B.N.; Yeom, K.W.; Shpanskaya, K.; Blankenberg, F.G.; Seekins, J.; Amrhein, T.J.; Mong, D.A.; Halabi, S.S.; Zucker, E.J.; Ng, A.Y.; Lungren, M.P. Deep learning for chest radiograph diagnosis: A retrospective comparison of the CheXNeXt algorithm to practicing radiologists. PLoS Med., 2018, 15(11), e1002686.
[http://dx.doi.org/10.1371/journal.pmed.1002686] [PMID: 30457988]
[90]
Beam, A.L.; Kohane, I.S. Big data and machine learning in health care. JAMA, 2018, 319(13), 1317-1318.
[http://dx.doi.org/10.1001/jama.2017.18391] [PMID: 29532063]
[91]
Kelly, C.J.; Karthikesalingam, A.; Suleyman, M.; Corrado, G.; King, D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med., 2019, 17(1), 195.
[http://dx.doi.org/10.1186/s12916-019-1426-2] [PMID: 31665002]
[92]
Amann, J.; Blasimme, A.; Vayena, E.; Frey, D.; Madai, V.I. Explainability for artificial intelligence in healthcare: A multidisciplinary perspective. BMC Med. Inform. Decis. Mak., 2020, 20(1), 310.
[http://dx.doi.org/10.1186/s12911-020-01332-6] [PMID: 33256715]

Rights & Permissions Print Cite